Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New FDA rules target those ubiquitous TV drug commercials
The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers from knowing risk information about drugs.
FDA rule on TV drug ads: compliance boon or comprehension bust?
Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but should aid in drugmakers’ ability to meet the fair-balance standard.
FDA's New Rules Require TV Drug Ads to Be Clearer, More Direct
The new rules become binding on November 20, but many drug companies have already been acting within these requirements. Companies have always been required by the FDA to give a b
New FDA Rules for TV Drug Ads: Simpler Language and No Distractions
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when explaining their medications' risks and side effects.
FDA puts new restrictions on TV ads for drugs
The new rules instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon.
FiercePharma
4d
Autolus readies its CAR-T Aucatzyl to go after heavy hitter competition following FDA nod
Autolus is ready to hit the ground running after winning
FDA
approval for its Aucatzyl ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S.
commercial
distribution partner.
STAT
2d
BioNTech acquires its Chinese cancer drug partner
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
pharmaphorum
1d
PTC gets FDA okay for first brain-delivered gene therapy
Kebilidi is the first gene therapy approved by the FDA for administration directly into the brain, given via a cannula during ...
FiercePharma
10d
Vertex's Casgevy breaks ground with 1st commercial patient infusions as company readies another major launch for 2025
With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback